The drug, marketed as Wegovy for obesity and Ozempic for diabetes, has also transformed the prospects of Novo Nordisk
Trends in Cell Biology , 24 (8), 464471
This enhanced formulation combines semaglutide , a GLP-1 receptor agonist, with glycine , a conditionally essential amino acid known for its roles in detoxification, inflammation control, and mitochondrial function
Semaglutide is part of a class of drugs called glucagon-like peptide-1 (GLP-1) agonists
doi:10.1507/endocrj.EJ23-0384 About BrightFocus Foundation BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimers, macular degeneration, and glaucoma
Ozempic is a brand name used for diabetes, while Wegovy is used for weight loss.